Register entry

Kyongbo Pharmaceutical Co., Ltd.

Data as of · How to read this entry

Registered sites
1
Active NDC listings
1
Live patents
0
Countries
1
Base
South Korea
Authorisation

Registered operations

Analytical testing1Active ingredient (API) manufacture1
Sites

Registered establishments

1
EstablishmentAddressRegistered forFEI / DUNS
Kyongbo Pharmaceutical Co., Ltd.174 Sirok-Ro, Asan, Chungcheongnam-do 315-01, Korea, South (KOR)Analytical testing, Active ingredient (API) manufacture3003773799687781963
Catalogue

Marketed products

1
BrandGeneric nameForm / routeNDC
-LENALIDOMIDEpowder51065-009BULK INGREDIENT
Compare

Comparable companies in South Korea

Enquiry

Common questions

Is Kyongbo Pharmaceutical Co., Ltd. FDA approved?
Kyongbo Pharmaceutical Co., Ltd. holds 1 FDA-registered establishment in South Korea. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Kyongbo Pharmaceutical Co., Ltd.'s drugs manufactured?
The FDA register lists Chungcheongnam-do 315-01. Registered operations: analytical testing, active ingredient (API) manufacture.
What drugs does Kyongbo Pharmaceutical Co., Ltd. make?
1 product is listed under Kyongbo Pharmaceutical Co., Ltd. in the openFDA NDC Directory, most often as powder. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.